HealthCor Management as of March 31, 2019
Portfolio Holdings for HealthCor Management
HealthCor Management holds 48 positions in its portfolio as reported in the March 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Danaher Corporation (DHR) | 5.6 | $139M | 1.1M | 132.02 | |
UnitedHealth (UNH) | 5.6 | $138M | 557k | 247.26 | |
Zimmer Holdings (ZBH) | 5.5 | $136M | 1.1M | 127.70 | |
Medtronic (MDT) | 5.4 | $134M | 1.5M | 91.08 | |
Neurocrine Biosciences (NBIX) | 5.4 | $134M | 1.5M | 88.10 | |
Haemonetics Corporation (HAE) | 4.8 | $119M | 1.4M | 87.48 | |
Madrigal Pharmaceuticals (MDGL) | 4.5 | $112M | 892k | 125.26 | |
Merck & Co (MRK) | 4.2 | $105M | 1.3M | 83.17 | |
Allergan | 3.6 | $90M | 618k | 146.41 | |
Dex (DXCM) | 3.5 | $87M | 730k | 119.10 | |
Intersect Ent | 3.3 | $83M | 2.6M | 32.15 | |
Intuitive Surgical (ISRG) | 3.1 | $77M | 135k | 570.58 | |
Radius Health | 3.0 | $73M | 3.7M | 19.94 | |
Humana (HUM) | 2.8 | $69M | 258k | 266.00 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.5 | $62M | 339k | 183.95 | |
Iqvia Holdings (IQV) | 2.3 | $58M | 403k | 143.85 | |
Icon (ICLR) | 2.3 | $56M | 409k | 136.58 | |
Centene Corporation (CNC) | 2.2 | $54M | 1.0M | 53.10 | |
Horizon Pharma | 2.1 | $53M | 2.0M | 26.43 | |
Boston Scientific Corporation (BSX) | 2.0 | $50M | 1.3M | 38.38 | |
Medicines Company | 2.0 | $49M | 1.7M | 27.95 | |
Bluebird Bio (BLUE) | 1.9 | $48M | 303k | 157.33 | |
Stryker Corporation (SYK) | 1.9 | $47M | 240k | 197.52 | |
Thermo Fisher Scientific (TMO) | 1.7 | $43M | 158k | 273.72 | |
Becton, Dickinson and (BDX) | 1.7 | $41M | 165k | 249.73 | |
Gilead Sciences (GILD) | 1.6 | $41M | 624k | 65.01 | |
Myokardia | 1.5 | $38M | 731k | 51.99 | |
Wright Medical Group Nv | 1.5 | $37M | 1.2M | 31.45 | |
Clovis Oncology | 1.4 | $35M | 1.4M | 24.82 | |
Corindus Vascular Robotics I | 1.4 | $35M | 20M | 1.74 | |
Viewray (VRAYQ) | 1.2 | $31M | 4.2M | 7.39 | |
CONMED Corporation (CNMD) | 1.1 | $28M | 340k | 83.18 | |
Pacira Pharmaceuticals (PCRX) | 1.1 | $27M | 706k | 38.06 | |
CVS Caremark Corporation (CVS) | 0.9 | $22M | 400k | 53.93 | |
Hca Holdings (HCA) | 0.8 | $19M | 147k | 130.38 | |
Nevro (NVRO) | 0.7 | $16M | 257k | 62.51 | |
Irhythm Technologies (IRTC) | 0.6 | $16M | 212k | 74.96 | |
Iovance Biotherapeutics (IOVA) | 0.5 | $11M | 1.2M | 9.51 | |
Ironwood Pharmaceuticals (IRWD) | 0.4 | $10M | 747k | 13.53 | |
Ionis Pharmaceuticals (IONS) | 0.4 | $10M | 125k | 81.17 | |
Abbott Laboratories (ABT) | 0.4 | $9.6M | 120k | 79.94 | |
Select Medical Holdings Corporation (SEM) | 0.3 | $8.5M | 600k | 14.09 | |
Biohaven Pharmaceutical Holding | 0.3 | $7.8M | 152k | 51.47 | |
Genfit S A ads (GNFT) | 0.3 | $7.8M | 325k | 24.00 | |
Polarityte | 0.2 | $4.3M | 400k | 10.70 | |
Cymabay Therapeutics | 0.1 | $3.0M | 225k | 13.28 | |
Precision Biosciences Ord | 0.1 | $2.7M | 150k | 17.95 | |
Karyopharm Therapeutics (KPTI) | 0.1 | $1.7M | 296k | 5.84 |